Literature DB >> 14583372

Brain natriuretic peptide is elevated in outpatients with atrial fibrillation.

Helme Silvet1, Yinong Young-Xu, Diana Walleigh, Shmuel Ravid.   

Abstract

Brain natriuretic peptide (BNP) levels were measured in 72 outpatients with chronic atrial fibrillation (AF) and in 49 control patients without AF. BNP levels were significantly higher in patients with AF (median value 131 pg/ml) than without AF (median value 49 pg/ml; p <0.001), and remained significantly higher after controlling for demographic and clinical variables.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14583372     DOI： 10.1016/j.amjcard.2003.07.010

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  41 in total

1.  Elevated B-type natriuretic peptide level as a marker of subsequent thromboembolic events in patients with atrial fibrillation.

Authors:  Tsuneaki Sadanaga; Shun Kohsaka; Hideo Mitamura; Satoshi Ogawa
Journal:  Heart Vessels       Date:  2010-12-25       Impact factor: 2.037

Review 2.  Natriuretic peptide-guided treatment for the prevention of cardiovascular events in patients without heart failure.

Authors:  Claire Sweeney; Fiona Ryan; Mark Ledwidge; Cristin Ryan; Ken McDonald; Chris Watson; Rebabonye B Pharithi; Joe Gallagher
Journal:  Cochrane Database Syst Rev       Date:  2019-10-15

Review 3.  Clinical scores used for the prediction of negative events in patients undergoing catheter ablation for atrial fibrillation.

Authors:  Falco Kosich; Katja Schumacher; Tatjana Potpara; Gregory Y Lip; Gerhard Hindricks; Jelena Kornej
Journal:  Clin Cardiol       Date:  2019-01-14       Impact factor: 2.882

4.  B-type natriuretic peptide in patients with clinical hyperthyroidism.

Authors:  T Wei; C Zeng; Y Tian; Q Chen; L Wang
Journal:  J Endocrinol Invest       Date:  2005-01       Impact factor: 4.256

5.  Diagnostic accuracy of NT-proBNP ratio (BNP-R) for early diagnosis of tachycardia-mediated cardiomyopathy: a pilot study.

Authors:  Amir M Nia; Natig Gassanov; Kristina M Dahlem; Evren Caglayan; Martin Hellmich; Erland Erdmann; Fikret Er
Journal:  Clin Res Cardiol       Date:  2011-05-03       Impact factor: 5.460

6.  Characterization of cardiac oxidative stress levels in patients with atrial fibrillation.

Authors:  Ayako Okada; Yuichiro Kashima; Takeshi Tomita; Takahiro Takeuchi; Kazunori Aizawa; Masafumi Takahashi; Uichi Ikeda
Journal:  Heart Vessels       Date:  2014-09-27       Impact factor: 2.037

7.  N-terminal pro-B-type natriuretic peptide and stroke risk: the reasons for geographic and racial differences in stroke cohort.

Authors:  Mary Cushman; Suzanne E Judd; Virginia J Howard; Brett Kissela; Orlando M Gutiérrez; Nancy S Jenny; Ali Ahmed; Evan L Thacker; Neil A Zakai
Journal:  Stroke       Date:  2014-04-22       Impact factor: 7.914

8.  Diabetes is a predictor of coronary artery stenosis in patients hospitalized with heart failure.

Authors:  Tsuneharu Kosuga; Kimiaki Komukai; Satoru Miyanaga; Takeyuki Kubota; Kotaro Nakata; Kenichiro Suzuki; Takayuki Yamada; Jun Yoshida; Haruka Kimura; Michihiro Yoshimura
Journal:  Heart Vessels       Date:  2015-03-31       Impact factor: 2.037

9.  Elevated brain natriuretic peptide level in patients undergoing atrial fibrillation ablation: is it a predictor of failed ablation or a mere function of atrial rhythm and rate at a point in time?

Authors:  Jayasree Pillarisetti; Namratha Reddy; Mazda Biria; Kay Ryschon; Darbhamulla Nagarajan; Caroline Murray; Donita Atkins; Sudharani Bommana; Madhu Yeruva Reddy; Luigi DiBiase; Rhea Pimentel; Loren Berenbom; Buddhadeb Dawn; Andrea Natale; Dhanunjaya Lakkireddy
Journal:  J Interv Card Electrophysiol       Date:  2014-05-08       Impact factor: 1.900

10.  Characteristics of acute congestive heart failure with normal ejection fraction and less elevated B-type natriuretic peptide.

Authors:  Ken Shimamoto; Natsuha Koike; Kiyoko Mizuochi; Miho Honma; Yufuko Kasai; Akiko Sakai; Etsuko Fujita; Masatoshi Kawana
Journal:  BMC Cardiovasc Disord       Date:  2009-01-24       Impact factor: 2.298
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.